The Impact Of Tp53 Mutations On Egfr Mt Plus Nsclc Iv Patients Treated With 3rd Generation Tki On 2nd Line Or Further Line Therapy: Real-World Data From Two Certified Lung Cancer Centers In Germany
JOURNAL OF THORACIC ONCOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要